Wenbo He
- Molecular Biology
- Oncology
- Complementary and alternative medicine top 5%
- Epidemiology
- Pulmonary and Respiratory Medicine
- Co-authors
- Liansha TangMeixuan LiYuwen ZhouXuemei HanShu‐Sheng LiuMeng WangWeimin LiQin Zhang
- Topics
- Meningioma and schwannoma management (7 papers)Health Systems, Economic Evaluations, Quality of Life (4 papers)Neurofibromatosis and Schwannoma Cases (4 papers)
In The Last Decade
Wenbo He
57 papers receiving 865 citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 185
- Oncology 159
- Complementary and alternative medicine 105
- Epidemiology 96
- Pulmonary and Respiratory Medicine 88
Countries citing papers authored by Wenbo He
This map shows the geographic impact of Wenbo He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbo He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbo He more than expected).
Fields of papers citing papers by Wenbo He
This network shows the impact of papers produced by Wenbo He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbo He. The network helps show where Wenbo He may publish in the future.
Co-authorship network of co-authors of Wenbo He
This figure shows the co-authorship network connecting the top 25 collaborators of Wenbo He. A scholar is included among the top collaborators of Wenbo He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenbo He. Wenbo He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 22 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 17 | |
| 11 | 1 | |
| 12 | 43 | |
| 13 | 12 | |
| 14 | 4 | |
| 15 | 28 | |
| 16 | 74 | |
| 17 | 11 | |
| 18 | 17 | |
| 19 | 33 | |
| 20 | MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression. | 23 |
About Wenbo He
Wenbo He is a scholar working on Leadership and Management, Issues, ethics and legal aspects and Geriatrics and Gerontology, having authored 64 papers that have together received 883 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Neurofibromatosis and Schwannoma Cases (4 papers). The work is most often cited by research in Complementary and alternative medicine (105 citations), Oncology (159 citations) and Health (47 citations). Wenbo He has collaborated with scholars based in China, Singapore and Canada. Frequent co-authors include Liansha Tang, Meixuan Li, Yuwen Zhou, Xuemei Han, Shu‐Sheng Liu, Meng Wang, Weimin Li, Qin Zhang, Lili Jiang and Kehu Yang. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.